Advancing In-Line PAT Solutions For Real-Time Batch Analysis

Biopharmaceutical manufacturing is moving away from the limitations of reactive, offline sampling toward a model of continuous, data-driven process control. Achieving this shift requires embedding advanced Process Analytical Technology (PAT) directly into the workflow to capture metabolic insights as they happen. By utilizing non-invasive, media-agnostic electrochemical sensors, teams can monitor glucose and lactate levels without risking sterility or altering media composition.

This high-resolution data allows for more precise feeding strategies and the early detection of culture stress, which are critical for reducing batch variability and improving overall yield. Beyond the lab, these technologies are facilitating non-destructive batch release testing in clinical tissue graft applications, ensuring quality without sacrificing the product. Transitioning to in-line monitoring supports robust Quality by Design (QbD) principles and accelerates development timelines. View the on-demand webinar to explore the technical implementation of scalable, real-time metabolic monitoring.